Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.050
-0.110 (-2.64%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Molecular Partners AG Balance Sheet
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 64.25 | 82.65 | 63.87 | 67.31 | 87.95 | 71.81 |
Short-Term Investments | 14.52 | 10.41 | 85.57 | 119.58 | 161.2 | 61 |
Cash & Short-Term Investments | 78.77 | 93.06 | 149.44 | 186.89 | 249.14 | 132.81 |
Cash Growth | -39.83% | -37.73% | -20.04% | -24.99% | 87.59% | -23.55% |
Accounts Receivable | 2.31 | 1.83 | 2.32 | 1.95 | 1.02 | 25.65 |
Other Current Assets | 1.85 | 1.99 | 2.53 | 3.62 | 4.59 | 5.73 |
Total Current Assets | 82.93 | 96.88 | 154.28 | 192.46 | 254.75 | 164.19 |
Net Property, Plant & Equipment | 4.73 | 5.23 | 4.2 | 5.68 | 7.24 | 8.15 |
Other Intangible Assets | 0 | 0 | 0.05 | 0.21 | 0.27 | 0.33 |
Total Assets | 87.66 | 102.11 | 158.53 | 198.35 | 262.26 | 172.67 |
Accounts Payable | 2.09 | 1.93 | 1.86 | 1.33 | 2.14 | 7.39 |
Accrued Expenses | 5.67 | 8.06 | 7.71 | 7.55 | 7.5 | 9.98 |
Current Portion of Leases | 2.14 | 1.21 | 1.22 | 1.21 | 1.2 | 1.19 |
Unearned Revenue | - | - | - | - | 6.41 | 28.31 |
Total Current Liabilities | 8.8 | 11.03 | 10.79 | 14.42 | 17.25 | 46.87 |
Long-Term Leases | 1.21 | 2.44 | 1.23 | 2.44 | 3.65 | 4.85 |
Other Long-Term Liabilities | 8.11 | 8.15 | 4.88 | 9.4 | 6.19 | 13.66 |
Total Long-Term Liabilities | 10.41 | 10.75 | 6.11 | 7.51 | 9.84 | 18.51 |
Total Liabilities | 19.21 | 21.77 | 16.89 | 21.92 | 27.09 | 65.38 |
Common Stock | 4.04 | 4.04 | 4.04 | 3.64 | 3.6 | 3.23 |
Treasury Stock | -1.13 | -1.13 | -0.98 | -0.98 | -0.98 | - |
Additional Paid-in Capital | 390.17 | 389.18 | 384.88 | 365.53 | 360.32 | 355.01 |
Retained Earnings | -324.63 | -311.75 | -246.29 | -191.76 | -127.78 | -250.95 |
Shareholders' Equity | 68.45 | 80.33 | 141.64 | 176.43 | 235.17 | 107.29 |
Total Liabilities & Equity | 87.66 | 102.11 | 158.53 | 198.35 | 262.26 | 172.67 |
Total Debt | 3.34 | 3.64 | 2.44 | 3.65 | 4.85 | 6.04 |
Net Cash (Debt) | 75.42 | 89.41 | 147 | 183.24 | 244.29 | 126.77 |
Net Cash Growth | -41.43% | -39.17% | -19.78% | -24.99% | 92.70% | -23.86% |
Net Cash Per Share | 2.02 | 2.40 | 4.32 | 5.59 | 7.34 | 4.09 |
Book Value | 68.45 | 80.33 | 141.64 | 176.43 | 235.17 | 107.29 |
Book Value Per Share | 1.83 | 2.16 | 4.16 | 5.38 | 7.07 | 3.46 |
Tangible Book Value | 68.45 | 80.33 | 141.59 | 176.22 | 234.9 | 106.96 |
Tangible Book Value Per Share | 1.83 | 2.16 | 4.16 | 5.38 | 7.06 | 3.45 |